Abstract:Chemerin is an adipokine involved in inflammation, adipogenesis, angiogenesis and energy metabolism, and has been hypothesized as a link between obesity and type II diabetes. In humans affected by obesity, chemerin gene expression in peripheral tissues and circulating levels are elevated. In mice, plasma levels of chemerin are upregulated by high-fat feeding and gain and loss of function studies show an association of chemerin with body weight, food intake and glucose homeostasis. Therefore, chemerin is an important blood-borne mediator that, amongst its other functions, controls appetite and body weight. Almost all studies of chemerin to date have focused on its release from adipose tissue and its effects on peripheral tissues with the central effects largely overlooked. To demonstrate a central role of chemerin, we manipulated chemerin signaling in the hypothalamus, a brain region associated with appetite regulation, using pharmacological and genetic manipulation approaches. Firstly, the selective chemerin receptor CMKLR1 antagonist α-NETA was administered i.c.v. to rats to test for an acute physiological effect. Secondly, we designed a short-hairpin-RNA (shRNA) lentivirus construct targeting expression of CMKLR1. This shRNA construct, or a control construct was injected bilaterally into the arcuate nucleus of male Sprague Dawley rats on high-fat diet (45%). After surgery, rats were maintained on high-fat diet for 2 weeks and then switched to chow diet for a further 2 weeks. We found a significant weight loss acutely and inhibition of weight gain chronically. This difference became apparent after diet switch in arcuate nucleus-CMKLR1 knockdown rats. This was not accompanied by a difference in blood glucose levels. Interestingly, appetite-regulating neuropeptides remained unaltered, however, we found a significant reduction of the inflammatory marker TNF-α suggesting reduced expression of CMKLR1 protects from high-fat diet induced neuroinflammation. In white and brown adipose tissue, mRNA expression of chemerin, its receptors and markers of adipogenesis, lipogenesis and brown adipocyte activation remained unchanged confirming that the effects are driven by the brain. Our behavioral analyses suggest that knockdown of CMKLR1 had an impact on object recognition. Our data demonstrate that CMKLR1 is functionally important for the central effects of chemerin on body weight regulation and neuroinflammation.

Chemerin As an Inducer of Β Cell Proliferation Mediates Mitochondrial Homeostasis and Promotes Β Cell Mass Expansion.

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Chemerin Located in Bone Marrow Promotes Osteogenic Differentiation and Bone Formation Via Akt/Gsk3β/β‐catenin Axis in Mice

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Regulatory Effect of Chemerin and Therapeutic Efficacy of Chemerin‑9 in Pancreatogenic Diabetes Mellitus

Aerobic exercise-induced decrease of chemerin improved glucose and lipid metabolism and fatty liver of diabetes mice through key metabolism enzymes and proteins

The Chemerin-CMKLR1 Axis is Functionally important for Central Regulation of Energy Homeostasis

Adipocyte-derived Chemerin Rescues Lipid Overload-Induced Cardiac Dysfunction

The Role of Chemerin in Metabolic and Cardiovascular Disease: A Literature Review of Its Physiology and Pathology from a Nutritional Perspective

Chemerin deficiency regulates adipogenesis is depot different through TIMP1

Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes

Chemical Strategies for Pancreatic Β Cell Differentiation, Reprogramming, and Regeneration

Independent Association of Circulating Level of Chemerin With Functional and Early Morphological Vascular Changes in Newly Diagnosed Type 2 Diabetic Patients

Is Chemerin Associated with Gestational Diabetes Mellitus? an Evidence-Based Clinical Research from Chinese Women

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Chemerin affects blood lipid of high-fat diet male mice at sedentary and exercise states and its mechanisms

Targeted Pharmacological Therapy Restores Beta-Cell Function For Diabetes Remission

Exendin-4 Promotes Beta Cell Proliferation Via PI3k/Akt Signalling Pathway.

Mitofusin2 Promotes Β Cell Maturation from Mouse Embryonic Stem Cells Via Sirt3/Idh2 Activation

Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages